Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Gastroesophageal reflux disease (GERD) and non-erosive reflux sickness (NERD) are conventional gastrointestinal disorders characterized by way of the reflux of belly acid into the esophagus, leading to symptoms that include heartburn, regurgitation, and chest pain. The high prevalence of these situations, affecting thousands and thousands of individuals internationally, drives the demand for effective treatment options and impacts market dynamics considerably. Advances in diagnostic strategies, including top endoscopy, ambulatory pH monitoring, and esophageal manometry, have progressed the analysis and characterization of GERD and NERD Treatment. Accurate diagnosis is crucial for steering remedy selections and monitoring disease development, impacting market dynamics with the aid of influencing treatment choice and affected person results. The treatment panorama for GERD and NERD Treatment consists of lifestyle changes, pharmacological healing procedures, and surgical interventions aimed at lowering acid reflux disease, assuaging signs, and preventing headaches. Proton pump inhibitors (PPIs) are typically prescribed as first-line pharmacological remedies for GERD and NERD Treatment. However, a few patients may require alternative remedies, which include histamine receptor antagonists (H2RAs), antacids, or surgical interventions like fundoplication.
The market for GERD and NERD treatment is characterized by extreme competition among pharmaceutical organizations, medical tool manufacturers, and healthcare carriers. Market dynamics are prompted by means of elements such as product innovation, pricing strategies, distribution channels, and strategic collaborations. Companies attempt to distinguish their products through advanced capabilities, improved efficacy, and patient-pleasant formulations to benefit a competitive side inside the market. Patient preferences, such as treatment adherence and first-class of existence effects, affect the adoption of particular treatment modalities in the GERD and NERD Treatment market. Improvements in symptom management, symptom remedy, and long-term quality of lifestyles are key considerations for patients while deciding on remedy options. Patient-targeted care and shared selection-making contribute to market dynamics by shaping remedy picks and healthcare delivery trends. Regional versions in healthcare infrastructure, cultural attitudes toward GERD and NERD Treatment, and the right of entry to specialized care impact market dynamics.
Ongoing technological innovations in GERD and NERD Treatment remedies, which include minimally invasive endoscopic tactics, wi-fi pH monitoring devices, and impedance checking out, make contributions to the evolving market dynamics. These improvements improve diagnostic accuracy, treatment efficacy, and patient effects, addressing unmet needs and riding the demand for innovative answers in reflux management. Investment in studies and development efforts for GERD and NERD Treatment remedies is driven by elements that include market demand, technological advancements, and regulatory incentives. Funding from authorities, businesses, personal buyers, and philanthropic corporations supports innovation inside the GERD and NERD Treatment market and impacts market dynamics. The GERD and NERD Treatment remedy market is anticipated to witness a persistent increase and innovation pushed via improvements in technology, growing demand for patient-centered care, and a growing emphasis on personalized remedies in healthcare. Collaboration between stakeholders, funding in studies and development efforts, and coverage initiatives geared toward enhancing admission to specialized care will play an essential position in shaping the destiny dynamics of the GERD and NERD Treatment market.
GERD and NERD Treatment Market Highlights:
Americas GERD & NERD Treatment Market
Over the last two hundred years, acid reflux has been a common lifestyle problem and also experienced a few setbacks in the U.S. Though, the ultimate goal of the gastroesophageal reflux treatment has always remained the same, which is to suppress the symptoms of the GERD patient. GERD affects up to 40% of the U.S. population in their lifetime and is a part of an increasingly significant public health burden. When GERD is not properly managed, it can lead to Barrett's esophagus. The lifetime risk of progression from GERD to Barrett's esophagus is 26.5%. Early diagnosis and treatment of Barrett's esophagus are crucial because it is the primary risk factor for esophageal cancer. The incidence of acid reflux disorder, also known as heartburn, is rapidly increasing worldwide. Various studies state that almost every person experiences acid reflux once in a lifetime. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives but also extends to the healthcare system and economy.
The major driving factors for growth of the Americas GERD & NERD treatment market are increasing cases of smoking, rising cases of reflux disorder during pregnancy, changing lifestyle, and irregular dietary habits. Moreover, increasing incidence of acid reflux disorder (heartburn), growing geriatric population are likely to fuel the market growth during the forecast period.  Â
The Americas GERD & NERD treatment market is expected to grow USD 4.99 at the CAGR of 6.20% during the forecast period 2023-2030
Figure- Americas GERD & NERD treatment market, by End User 2016 (%)
 
Source: Source: World Health Organisation, Ministry of Health U.S, Department of Pharmaceutical, National Institute on Drug abuse, American Gastroenterological Association, American College of Gastroenterology, Pediatric/Adolescent Gastroesophageal Reflux Associatestinal Society Anxiety and Depression Association of America, and white papers published by various government organizations, MRFR Analysis
Intended Audience:
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Research Methodology:
Source: National Center for Biotechnology Information, U.S. National Library of Medicine, U.S. Food and Drug Administration, National Institute of Standards and Technology, U.S. Department of Commerce, Eurostat, Cambridge University Hospitals, Directorate of Industries, Expert Interviews, Annual reports, White paper, Company Presentation, MRFR Analysis
Segmentation
The Americas GERD & NERD treatment market is segmented on the basis of drug class, dosage form, and by the end user.
On the basis of the drug class, the Americas GERD & NERD treatment market is segmented into antacids (acid neutralizers), proton pump inhibitors, H2 receptor blocker, prokinetic agents, antidepressants, calcium channel blockers, and others. Proton pump inhibitors are further segmented into esomeprazole, omeprazole, pantoprazole, lansoprazole, dexlansoprazole, rabeprazole, and others. H2 receptor blocker is further segmented into ranitidine, famotidine, cimetidine, nizatidine, and others. Prokinetic agents are further segmented into domperidone, metoclopramide, itopride, prucalopride, cisapride, benzamide, mosapride, erythromycin, and others.
Based on the dosage form, Americas GERD & NERD treatment market is segmented into solid and liquid.
On the basis of the end user, Americas GERD & NERD treatment market is segmented into hospitals & clinics, research centers, and others.
Regional Analysis
The Americas GERD & NERD treatment market is growing at a steady pace. North America contributed the largest share to the GERD & NERD treatment market owing to continuously increasing demand for the medical devices, increasing number of healthcare organization, and the presence of huge patient population. Increasing cases of smoking are projected to fuel in the Americas market. The South American region accounts the least share of the market.
Key Findings:
- Antacids segment dominates the market with nearly 26.11% share of the Americas GERD & NERD treatment market
- Americas GERD & NERD treatment market was estimated to be USD 2,350.37 million in 2016
- Proton pump inhibitors segment is expected to be the second largest market, which is expected to reach USD 773.62 million by 2023
Key Players in the Americas GERD & NERD Treatment Market
Some of the major players in Americas GERD & NERD treatment are: AstraZeneca Plc (U.K), Boston Scientific Corporation (U.S.), Cempra Inc. (U.S.), Eisai Co., Ltd. (Japan), EndoGastric Solutions Inc. (U.S.), EndoStim Inc. (U.S.), GlaxoSmithKline Plc (U.K), Ironwood Pharmaceuticals, Inc. (U.S.), Jeil pharmaceutical Co. Ltd. (South Korea), Johnson & Johnson (U.S.), Mederi Therapeutics Inc. (U.S.), Medigus Ltd. (Israel), Medtronic Inc. (U.S.), Merck & CO., Inc. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceuticals Industries Limited (Israel), Torax Medical (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Carbon Medical technologies (U.S.), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), and Sanofi (France).
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
